Anales de la RANM

281 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 PATOLOGÍA CARDIOVASCULAR Y SÍNDROME DE APNEA DEL SUEÑO An RANM. 2024;141(03): 274 - 281 Alonso Formento JE, et al. En general, los pacientes con SAOS evidenciaron un perfil demográfico y clínico distintivo en el entorno de urgencias, acompañado de una mayor mortalidad durante el periodo de seguimiento analizado. DECLARACIÓN DE TRANSPARENCIA Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. No hay fuentes de financiación del trabajo. Los datos han sido extraídos de la historia clínica electrónica sin identificador del paciente y de forma anónima BIBLIOGRAFÍA 1. Laczay B, Faulx M. Obstructive sleep apnea and cardiac arrhythmias: a contemporary review. J Clin Med. 2021; 10(17): 3785. 2. Martí-Almor J, Jiménez-López J, Casteigt B et al. Obstructive sleep apnea syndrome as a tri- gger of cardiac arrhythmias. Curr Cardiol Rep. 2021; 23(3): 29. 3. Lopez-Jimenes F, Sert Kuniyoshi F, Gami A, So- mers V. Obstructive sleep apnea: Implications for cardiac and vascular disease; part II: Con- temporary reviews in sleep medicine. Chest. 2008; 133: 793-804. 4. Badran M, Ayas N, I Laher. Cardiovascular com- plications of sleep apnea: Role of oxidative stress. Oxid Med Cell Longev. 2014; 2014: 985258. 5. Eisenberg E, Zimlichman R, Lavie P. Plasma no- repinephrine levels in patients with sleep apnea syndrome. N Engl J Med. 1990; 322(13): 32-933. 6. Cazco M, Lorenzi-Filho G. Síndrome de apnea obs- tructiva del sueño y sus consecuencias cardiovascula- res. Rev Med Clin Condes. 2021; 32(5): 61-569. 7. Browman C, Sampson M, Yolles S et al. Obstructive sleep and body weight. Chest. 1984; 85: 435-436. 8. Nagappa M, Liao P, Wong J et al. Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea among diffe- rent populations: a systematic review and meta- analysis. PloS One. 2015; 10(12): e0143697. 9. JordanAS,McSharryDG,MalhotraA. Adult obstructive sleep apnea. Lancet. 2014; 383 (9918): 736-747. 10. Keenan S, Burt H, Ryan C, Fleetham J. Long-term survival of patients with obstructive sleep ap- nea treated by uvulopalatopharyngoplasty or nasal CPAP. Chest. 1994; 105(1): 155-159. 11. Drager L, Yao Q, Hernandez K et al. Chronic in- termittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Resp Crit Care. 2013; 188: 240-248. 12. Yeghiazarians Y, Jneid H, Tietjens J et al. Obs- tructive sleep apnea and cardiovascular disease. Circulation. 2021; 144: e56-e67. 13. Digby G, Baranchuk A. Sleep apnea and atrial fibrillation; 2012 update. Curr Cardiol Reviews. 2012; 8: 265-272. 14. Chen H, Zhang Q, Hao Y, Zhang J, He Y, Hu K. Cardiac autonomic dysfunction and structural remodeling: the potential mechanism to media- te the relationship between obstructive sleep apnea and cardiac arrhythmias. Front Med (Lausanne). 2024; 11: 1346400. 15. Geovanini G, Lorenzi-Filho G. Cardiac rhythm disorders in obstructive sleep apnea. J Thorac Dis. 2018; 10(Suppl 34): S4221-S4230. 16. Guilleminault C, Connolly S, Winkle R. Car- diac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983; 52: 490-494. 17. Arias M, Sánchez A. Obstructive sleep apnea and its relationship to cardiac arrhythmias. J Cardiovasc Electr. 2007; 18: 1006-1014. 18. Monahan K, Brewster J, Wang L et al. Relation of the severity of obstructive sleep apnea in res- ponse to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012; 110(3): 369-372. 19. Barón A, Páez-Moya S. Repercusiones cardio- vasculares del síndrome de apnea-hipopnea obstructiva del sueño (SAHOS). Rev Fac Med 2017; 65(Supl): S39-46. 20. Shah N, Yaggi H, Concato J, Mohsenin V. Obs- tructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath. 2010; 14: 131-136. 21. Brill A, Horvath T, Seiler A et al. CPAP as treatment of sleep apnea after stroke: a meta- analysis of randomized trials. Neurology. 2018; 90: e1222-e1230. 22. Bosanquet J, Bade B, Zia M, Karo A, Hassan O, Hess B, et al. Patients with venous thromboembo- lism appear to have higher prevalence of obstruc- tive sleep apnea than the general population. Clin Appl Thromb Haemost. 2011; 17(6): E119-124. 23. Arnulf I, Merino-Andreu M, Perrier A, Biro- lleau S, Similowski T, Derenne JP. Obstructi- ve sleep apnea and venous thromboembolism. JAMA. 2002; 287(20): 2655-2656. 24. Patil S, Ayappa I, Caples S, Kimoff R, Patel S, Harrod C. Treatment of adult obstructive sleep apnea with positive airway pressure: an Ameri- can Academy of Sleep Medicine systematic re- view, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2019; 15: 301-334. 25. Domaradzki D, Lelakowski J, Konieczyńska M, Matusik P. Continuous positive airway pressure treatment reduces ventricular arrhythmias in obstructive sleep apnea patients with noctur- nal dominance of arrhythmias and severe des- aturations. Pol Arch Intern Med. 2022; 132(6): 16236. Si desea citar nuestro artículo: Alonso Formento JE, Alonso Envid I, Estabén Boldova V, Pueyo Morer MJ, de Azúa Jiménez M, Garcés San José C.Patología cardio- vascular asociada al síndrome de apnea obstructiva del sueño. An RANM. 2024;141(03): 274– 281. DOI: 10.32440/ar.2024.141.03. org03